Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission.

Pierre-Yves DumasEmilie BérardClaire BréalStéphanie DulucqDelphine ReaFranck NicoliniEdouard ForcadeMelody DufosséeJean-Max PasquetBéatrice TurcqAudrey BidetNoel MilpiedJulie Déchanet-MervilleXavier LafargeGabriel EtienneFrançois-Xavier Mahonnull null

Published in: Cancer medicine (2019)

These results suggest that KIR2DL5B could carry a role in lymphocyte-mediated control of leukemic residual disease control in patient with CML relapse.

Keyphrases

chronic myeloid leukemia
case report
acute myeloid leukemia
peripheral blood
disease activity
rheumatoid arthritis
systemic lupus erythematosus
combination therapy
ulcerative colitis